Skip to main content
. Author manuscript; available in PMC: 2013 Oct 23.
Published in final edited form as: Neurol Res. 2013 Mar 15;35(7):693–700. doi: 10.1179/1743132813Y.0000000190

Figure 2.

Figure 2

Comparisons of CD40L and high-sensitivity C-reactive protein (hs-CRP) between healthy controls and patients with carotid artery stenosis (CAS), small-artery occlusion (SAO), large-artery atherosclerosis (LAA), and cardioaortic embolism (CAE). (A) Mean fluorescence intensity (MFI) of CD40L on peripheral blood monocytes as assessed by flow cytometry. **P<0.01 versus control; ††P<0.01 versus CAS; ##P<0.01 versus SAO or CAE. (B) Serum hs-CRP levels. *P<0.05, **P<0.01 versus control; †P<0.05, ††P<0.01 versus CAS; ##P<0.01 versus SAO or LAA. (C) Serum sCD40L levels. **P<0.01 versus control; †† P<0.01 versus CAS; ##P<0.01 versus SAO.